询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Allyltrimethoxysilane | CAS:2551-83-9
Allyltrimethoxysilane
  • 名称:烯丙基三甲氧基硅烷 | Allyltrimethoxysilane
  • CAS号:2551-83-9
  • 别名:Trimethoxy-2-propenylsilane; A 1504; Z 6825
  • 分子式:C6H14O3Si
  • 分子量:162.26
  • EINESC号:219-855-8

产品描述

物理化学性质

沸点 111 ºC
闪点 17 ºC
密度 0.914

安全数据

危险品标志 Xi
危险类别码 R10;R36/37/38
安全说明书 S26;S36

SDS

来源 SDS样本
Sigma-Aldrich 浏览或下载
TCI 浏览或下载
Acros-Organics 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
[A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin].Rie Kondo et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(13), 2607-2609 (2015-01-18) Impact of itraconazole on the survival of heavily pre-treated patients with triple-negative breast cancer.Hiroshi Tsubamoto et al.Anticancer research, 34(7), 3839-3844 (2014-07-02) A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.R M Glasspool et al.British journal of cancer, 110(8), 1923-1929 (2014-03-20) A case of pulmonary mucoepidermoid carcinoma responding to carboplatin and paclitaxel.Shoko Sonobe et al.Japanese journal of clinical oncology, 44(5), 493-496 (2014-03-13) Fast, Stable Induction of P-Glycoprotein-mediated Drug Resistance in BT-474 Breast Cancer Cells by Stable Transfection of ABCB1 Gene.Yuan Tang et al.Anticancer research, 35(5), 2531-2538 (2015-05-13) Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells.Samaya R Krishnan et al.Breast cancer research and treatment, 150(3), 487-499 (2015-03-20) Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.Huan Wang et al.Oncology reports, 33(1), 403-412 (2014-10-30) Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.Erin M Sullivan et al.Journal of pediatric hematology/oncology, 36(6), e335-e340 (2014-03-01) USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.Mun Sem Liew et al.BJU international, 112 Suppl 2, 74-82 (2013-10-30) Thomas' Hematopoietic Cell Transplantation, Volume 457 (2004) Involvement of the DNA mismatch repair system in antineoplastic drug resistance.H Lage et al.Journal of cancer research and clinical oncology, 125(3-4), 156-165 (1999-05-11) Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.Limei Yan et al.Biochimie, 113, 17-25 (2015-03-03) Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.Jeremy Lewin et al.European journal of nuclear medicine and molecular imaging, 42(1), 25-32 (2014-08-16) Tumor lysis syndrome in a nonsmall cell lung cancer.Adam M Noyes et al.Connecticut medicine, 78(7), 421-423 (2014-09-10) NMR cryoporometry characterisation studies of the relation between drug release profile and pore structural evolution of polymeric nanoparticles.Navin Gopinathan et al.International journal of pharmaceutics, 469(1), 146-158 (2014-04-15) Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.Tiago B de Castria et al.The Cochrane database of systematic reviews, 8(8), CD009256-CD009256 (2013-08-21) Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.B Bhattacharya et al.British journal of pharmacology, 171(13), 3255-3267 (2014-03-07) Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.Julia C Meier et al.Cancer medicine, 4(2), 253-267 (2014-12-11) Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.Punnada Athibovonsuk et al.Gynecologic oncology, 131(3), 679-682 (2013-10-09) PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples.Boris Winterhoff et al.European journal of cancer (Oxford, England : 1990), 51(7), 879-892 (2015-03-11) Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma.Shilpen A Patel et al.American journal of clinical oncology, 38(1), 47-50 (2015-01-24) PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.Jyoti D Patel et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(34), 4349-4357 (2013-10-23) Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients.Jan B Hulshoff et al.American journal of surgery, 208(1), 73-79 (2014-01-31) Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report.Daisuke Morichika et al.Japanese journal of clinical oncology, 44(5), 501-505 (2014-03-22) Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.Corey J Langer et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(19), 2059-2066 (2014-06-04) Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer.Leslie S Bradford et al.Gynecologic oncology, 133(2), 346-352 (2014-02-25) Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of tea.Martin Fehr et al.European journal of cancer (Oxford, England : 1990), 50(12), 2176-2177 (2014-06-12) shRNA Depletion of cIAP1 Sensitizes Human Ovarian Cancer Cells to Anticancer Agent-Induced Apoptosis.Hong Jin et al.Oncology research, 22(3), 167-176 (2015-07-15) Efficacy of cetuximab in the treatment of squamous cell carcinoma.Sophie Preneau et al.The Journal of dermatological treatment, 25(5), 424-427 (2012-11-22) Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs.Noriaki Hashimoto et al.BMC cancer, 14, 722-722 (2014-09-28) Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.Jeffrey S Weber et al.The Lancet. Oncology, 16(4), 375-384 (2015-03-22) Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.Naike Casagrande et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 20(21), 5496-5506 (2014-09-19) [A case of poorly differentiated adenocarcinoma of the uterine cervix treated with paclitaxel and carboplatin after positive PAX 8 immunostaining].Takahide Maenaka et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(10), 1413-1417 (2013-11-08) Calpain system protein expression and activity in ovarian cancerZhang S, et al. Journal of Cancer Research and Clinical Oncology, 1-17 (2018) Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.Stefan Vallo et al.Translational oncology, 8(3), 210-216 (2015-06-10) Trastuzumab, in combination with carboplatin and docetaxel, does not prolong the QT interval of patients with HER2-positive metastatic or locally advanced inoperable solid tumors: results from a phase Ib study.Na Xu et al.Cancer chemotherapy and pharmacology, 74(6), 1251-1260 (2014-10-27) MicroRNA biogenesis and cellular proliferation.Divya Lenkala et al.Translational research : the journal of laboratory and clinical medicine, 166(2), 145-151 (2015-03-01) Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.Yoo-Young Lee et al.Anticancer research, 33(10), 4675-4681 (2013-10-15) Radiation dose in non-small cell lung cancer: too much of a good thing?Thomas J Dilling International journal of radiation oncology, biology, physics, 90(5), 979-982 (2014-12-30) Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.Limei Yan et al.Biochimie, 113, 17-25 (2015-03-03) Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells.Zengli Zhang et al.Oncology letters, 8(3), 1348-1354 (2014-08-15) Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation.Jonas Philipp Becker et al.Toxicology letters, 225(1), 43-47 (2013-11-28) KRAS mutation as the biomarker of response to chemotherapy and EGFR-TKIs in patients with advanced non-small cell lung cancer: clues for its potential use in second-line therapy decision making.Alma D Campos-Parra et al.American journal of clinical oncology, 38(1), 33-40 (2013-03-30) Applicability of the concept of "platinum sensitivity" to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup study.Shoji Nagao et al.Gynecologic oncology, 131(3), 567-573 (2013-10-01) [Cisplatin or carboplatin, that is the question].Coralie Moncharmont et al.Bulletin du cancer, 98(2), 164-175 (2011-03-09) Paclitaxel and carboplatin-induced complete remission in peritoneal carcinomatosis of unknown origin: a report of two cases and review of the literature.Yi-Ying Wu et al.Tumori, 96(2), 336-339 (2010-06-25) Maintenance therapy in non-small cell lung cancer.Giovenzio Genestreti et al.Expert review of anticancer therapy, 15(7), 839-846 (2015-06-02) Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.Ji Ho Kang et al.Experimental biology and medicine (Maywood, N.J.), 240(11), 1416-1425 (2015-02-27) Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.Colleen Rivard et al.Gynecologic oncology, 135(2), 318-324 (2014-08-31) TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.Roisin M Connolly et al.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(1), 31-37 (2014-12-06) Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.Shinya Matsuzaki et al.International journal of cancer, 134(8), 1796-1809 (2013-10-24) Quantiosomes as a multimodal nanocarrier for integrating bioimaging and Carboplatin delivery.Chwan-Fwu Lin et al.Pharmaceutical research, 31(10), 2664-2676 (2014-06-08) Restoration of microRNA‑218 increases cellular chemosensitivity to cervical cancer by inhibiting cell‑cycle progression.Ruofan Dong et al.Molecular medicine reports, 10(6), 3289-3295 (2014-10-14) Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.Claire Bonneau et al.Gynecologic oncology, 136(1), 112-120 (2014-12-03) In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans.Dhrubajyoti Kalita et al.American journal of ophthalmology, 157(5), 1109-1115 (2014-02-08) Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab.Arvind M Shinde et al.Breast (Edinburgh, Scotland), 24(1), 18-23 (2014-12-04) Thomas' Hematopoietic Cell Transplantation, Volume 457 (2004) Involvement of the DNA mismatch repair system in antineoplastic drug resistance.H Lage et al.Journal of cancer research and clinical oncology, 125(3-4), 156-165 (1999-05-11) USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.Mun Sem Liew et al.BJU international, 112 Suppl 2, 74-82 (2013-10-30) Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.Juliet Kenicer et al.BMC cancer, 14, 762-762 (2014-10-15) Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation.Jonas Philipp Becker et al.Toxicology letters, 225(1), 43-47 (2013-11-28) Predictive and prognostic value of circulating endothelial cells in non-small cell lung cancer patients treated with standard chemotherapy.Fadi Najjar et al.Journal of cancer research and clinical oncology, 141(1), 119-125 (2014-07-20) Trastuzumab, in combination with carboplatin and docetaxel, does not prolong the QT interval of patients with HER2-positive metastatic or locally advanced inoperable solid tumors: results from a phase Ib study.Na Xu et al.Cancer chemotherapy and pharmacology, 74(6), 1251-1260 (2014-10-27) Calpain system protein expression and activity in ovarian cancerZhang S, et al. Journal of Cancer Research and Clinical Oncology, 1-17 (2018) Radiation dose in non-small cell lung cancer: too much of a good thing?Thomas J Dilling International journal of radiation oncology, biology, physics, 90(5), 979-982 (2014-12-30) Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.Stefan Vallo et al.Translational oncology, 8(3), 210-216 (2015-06-10) Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells.Zengli Zhang et al.Oncology letters, 8(3), 1348-1354 (2014-08-15) KRAS mutation as the biomarker of response to chemotherapy and EGFR-TKIs in patients with advanced non-small cell lung cancer: clues for its potential use in second-line therapy decision making.Alma D Campos-Parra et al.American journal of clinical oncology, 38(1), 33-40 (2013-03-30) Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.Irene Karam et al.American journal of clinical oncology, 38(1), 51-54 (2013-04-09) Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.Kevin J Lee et al.PloS one, 14(10), e0223725-e0223725 (2019-10-10) Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity.Dan Jin et al.PloS one, 14(10), e0223555-e0223555 (2019-10-11) Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.Guillermo L Chantada et al.Pediatric blood & cancer, 61(5), 821-826 (2013-11-19) Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin.Tiffany J Tzeng et al.PloS one, 9(7), e101664-e101664 (2014-07-11) Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization.Ana P Gomes et al.Cancer cell, 36(4), 402-417 (2019-10-01) Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer.Christopher T Cummings et al.Oncotarget, 5(21), 10434-10445 (2014-11-06) Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.Naike Casagrande et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 20(21), 5496-5506 (2014-09-19) [A case of poorly differentiated adenocarcinoma of the uterine cervix treated with paclitaxel and carboplatin after positive PAX 8 immunostaining].Takahide Maenaka et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(10), 1413-1417 (2013-11-08) Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.Sigalit Meker et al.Molecules (Basel, Switzerland), 20(10), 18526-18538 (2015-10-17) The Krüppel-type zinc finger family gene, HKR1, is induced in lung cancer by exposure to platinum drugs.T Oguri et al.Gene, 222(1), 61-67 (1998-11-14) Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.Kenya Kanazawa et al.Cancer chemotherapy and pharmacology, 74(6), 1149-1157 (2014-10-09) Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.Pang-ning Teng et al.Gynecologic oncology, 136(3), 554-561 (2015-01-07) High-dose chemotherapy for recurrent ovarian germ cell tumors.Natraj Reddy Ammakkanavar et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(2), 226-227 (2014-12-03) Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.Nadya Shusharina et al.International journal of radiation oncology, biology, physics, 89(1), 137-144 (2014-04-15) A hyposensitive anticancer drug induces higher surface expression and release of heat shock proteins in a human hepatocellular carcinoma cell line.Mei Yang et al.Molecular medicine reports, 12(2), 2879-2885 (2015-05-09) Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.Cecilia Lezcano et al.Laboratory investigation; a journal of technical methods and pathology, 94(10), 1092-1102 (2014-08-12) The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease.Ryoko Shimizu et al.Cancer chemotherapy and pharmacology, 74(6), 1159-1166 (2014-09-24) Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.Antonio Rossi et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(14), 1692-1698 (2012-04-05) Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy.Tao Chen et al.Journal of cellular and molecular medicine, 13(7), 1358-1370 (2008-05-10) Prevention of carboplatin-induced resistance in human ovarian tumor xenografts by selenite.Paula B Caffrey et al.Anticancer research, 33(10), 4249-4254 (2013-10-15) Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.Anne M Friel et al.Cancer letters, 356(2 Pt B), 434-442 (2014-10-12) Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.Kevin J Lee et al.PloS one, 14(10), e0223725-e0223725 (2019-10-10) Graphene oxide - gelatin nanohybrids as functional tools for enhanced Carboplatin activity in neuroblastoma cells.Sami Makharza et al.Pharmaceutical research, 32(6), 2132-2143 (2014-12-30) Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.K Narui et al.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 41(1), 94-99 (2014-09-24) The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease.Ryoko Shimizu et al.Cancer chemotherapy and pharmacology, 74(6), 1159-1166 (2014-09-24) Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.Antonio Rossi et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(14), 1692-1698 (2012-04-05) Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity.Dan Jin et al.PloS one, 14(10), e0223555-e0223555 (2019-10-11) Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer.Qian Ding et al.Drug design, development and therapy, 7, 681-689 (2013-08-16) The tumor-suppressing activity of the prenyl diphosphate synthase subunit 2 gene in lung cancer cells.Ping Chen et al.Anti-cancer drugs, 25(7), 790-798 (2014-03-13) Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.Annemiek M van Maldegem et al.Pediatric blood & cancer, 62(1), 40-44 (2014-09-25) Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.Ulrike Keitel et al.Oncotarget, 5(23), 11778-11791 (2014-12-05) Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth.Ashwani Khurana et al.Oncotarget, 6(34), 36354-36369 (2015-10-27) Epigenetic targeting of ovarian cancer stem cells.Yinu Wang et al.Cancer research, 74(17), 4922-4936 (2014-07-19) Case report and review of literature: temporary asymptomatic sinus bradycardia with carboplatin, paclitaxel and bevacizumab: under-reported in clinical trials and under-disclosed in practice.J M Zekri The Gulf journal of oncology, (10)(10), 60-64 (2011-07-05) [A case of malignant peritoneal mesothelioma diagnosed with laparoscopic biopsy].Yasumichi Yagi et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(8), 995-997 (2014-08-19) Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy.Pedro J Beltran et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 2947-2958 (2014-04-15) Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature.E Hudson et al.European journal of cancer care, 19(3), 324-328 (2009-11-17) UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan.Satoshi Yamasaki et al.Annals of hematology, 94(1), 65-69 (2014-07-25) Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.Nabil F Saba et al.Cancer, 120(24), 3940-3951 (2014-08-12) Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.Sarah E Taylor et al.Gynecologic oncology, 134(1), 68-72 (2014-04-29) Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer.Jan Nyrop Jakobsen et al.Journal of cancer research and clinical oncology, 140(4), 645-652 (2014-02-25) Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.David R Spigel et al.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 10(2), 353-359 (2015-01-23) Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles.Bin Yang et al.Biomacromolecules, 16(2), 457-464 (2014-12-30) Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin.Tanmoy Sadhukha et al.AAPS PharmSciTech, 15(4), 1029-1038 (2014-05-17) Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.Richard M Steingart et al.Seminars in oncology, 40(6), 690-708 (2013-12-18) Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials.Furqan Shaikh et al.Pediatric blood & cancer, 60(4), 587-592 (2012-09-15) Determination methods for the anticancer drug dicycloplatin, a supramolecule assembled through hydrogen bonding.Xuqing Yang et al.The Analyst, 140(8), 2704-2712 (2015-02-17) Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.Koichi Takayama et al.Cancer chemotherapy and pharmacology, 72(6), 1353-1359 (2013-10-30) Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell Lines.Francisco Clemente-Vicario et al.PloS one, 10(11), e0142007-e0142007 (2015-11-13) Lack of a pharmacokinetic interaction between trastuzumab and carboplatin in the presence of docetaxel: results from a phase Ib study in patients with HER2-positive metastatic or locally advanced inoperable solid tumors.Stephen Eppler et al.Anti-cancer drugs, 26(4), 448-455 (2015-02-03) Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.Joyce O'Shaughnessy et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(34), 3840-3847 (2014-10-29) [Clinical experience of the use of pemetrexed (PEM) combined with cisplatin (CDDP)/Carboplatin (CBDCA) followed by long-term maintenance PEM in patients with non-squamous non-small cell lung cancer].Hisashi Ishikura et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(5), 623-626 (2014-06-12) CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.Erika Ortolan et al.Oncotarget, 5(15), 6191-6205 (2014-07-16) A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.Thomas C Krivak et al.American journal of obstetrics and gynecology, 211(1), 68-68 (2014-02-18) Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.Joel Shapiro et al.Annals of surgery, 258(5), 678-688 (2013-10-08) [Level of evidence for therapeutic drug monitoring of carboplatin].Anne Hulin et al.Therapie, 65(3), 157-162 (2010-08-12) Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.Matthew D Hall et al.Cancer research, 74(14), 3913-3922 (2014-05-09) Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.Ivana Sullivan et al.Cancer letters, 353(2), 160-166 (2014-07-30) Human monocytes in the presence of interferons alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatin.Chase L Johnson et al.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 35(1), 55-62 (2014-07-30) Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach.Gerald A Feuer et al.Gynecologic oncology, 131(3), 520-524 (2013-10-02) Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.Masaaki Kawahara et al.Anticancer research, 33(10), 4631-4637 (2013-10-15) Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC.Andrew J Massey PloS one, 10(7), e0134306-e0134306 (2015-07-29) Significance of SALL4 as a drug‑resistant factor in lung cancer.Nozomi Yanagihara et al.International journal of oncology, 46(4), 1527-1534 (2015-02-04) Complex decisions for first-line and maintenance treatment of advanced wild-type non-small cell lung cancer.Ryan D Gentzler et al.The oncologist, 20(3), 299-306 (2015-02-11) Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study.Kathrin Halfter et al.BMC cancer, 15, 519-519 (2015-07-15) Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer.Marco Petrillo et al.American journal of obstetrics and gynecology, 211(6), 632-632 (2014-06-24) A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201).Junko Eba et al.Japanese journal of clinical oncology, 45(1), 115-118 (2014-10-22) Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.Alexandra-Zoe Andrei et al.Cancer letters, 364(1), 8-16 (2015-04-14) Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery.Kohei Fukuoka et al.Journal of neurosurgery. Pediatrics, 13(1), 38-41 (2013-10-29) Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone.Kemal Alpay et al.PloS one, 9(8), e105526-e105526 (2014-08-26) Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.Edward A Levine et al.Journal of the American College of Surgeons, 218(4), 573-585 (2014-02-05) Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).George Au-Yeung et al.Gynecologic oncology, 133(1), 16-22 (2014-04-01) Selective toxicity of rose bengal to ovarian cancer cells in vitroKoevary SB International Journal of Physiology, Pathophysiology and Pharmacology, 4(2), 99-99 (2012) First-line crizotinib versus chemotherapy in ALK-positive lung cancer.Benjamin J Solomon et al.The New England journal of medicine, 371(23), 2167-2177 (2014-12-04) [Carboplatin plus irinotecan induced partial response in a patient with small cell carcinoma of the prostate; a case report].Hiroko Kimura et al.Hinyokika kiyo. Acta urologica Japonica, 60(1), 39-43 (2014-03-07) Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.Caroline Kreuzinger et al.Cancer letters, 362(2), 218-228 (2015-04-12) Using Drosophila melanogaster to identify chemotherapy toxicity genes.Elizabeth G King et al.Genetics, 198(1), 31-43 (2014-09-23) Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice.Raktim Biswas et al.Journal of photochemistry and photobiology. B, Biology, 148, 118-127 (2015-04-26) MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.Paul Zarogoulidis et al.Cellular signalling, 27(8), 1576-1588 (2015-04-29) Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature.Keisuke Watanabe et al.Tumori, 99(4), e172-e176 (2013-12-12) A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer.Domenica Lorusso et al.Gynecologic oncology, 133(1), 117-123 (2014-02-04) Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.Carol L Shields et al.Ophthalmology, 121(7), 1453-1460 (2014-03-25) A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype.Verena Rohnalter et al.Oncotarget, 6(37), 40005-40025 (2015-10-28) Carboplatin dosing in ovarian cancer: problems and pitfalls.Ian M Collins et al.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 21(7), 1213-1218 (2011-06-28) Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cellsAleksic T and Feller SM Cell communication and signaling : CCS, 6(1), 8-8 (2008) [Two cases of recurrent invasive mucinous adenocarcinoma of the lung showing marked responses to platinum-based chemotherapyregimens with pemetrexed and bevacizumab].Yasuko Koma et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(11), 1525-1528 (2013-11-16) Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited.G Natarajan et al.Biochemical pharmacology, 58(10), 1625-1629 (1999-10-27) A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.Juneko E Grilley-Olson et al.The oncologist, 20(2), 105-106 (2015-01-27) Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.Tatyana Feldman et al.British journal of haematology, 166(1), 77-83 (2014-03-26) Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.I Wilkinson-Ryan et al.Gynecologic oncology, 134(1), 24-28 (2014-05-16) Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.J Knezevic et al.Oncogene, 34(49), 5997-6006 (2015-03-10) Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin.Syed Hammad Tirmazy et al.Anticancer research, 34(7), 3793-3798 (2014-07-02) Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.Robert Fruscio et al.Gynecologic oncology, 131(3), 689-693 (2013-10-01) Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis.Chenguang Li et al.Lung, 188(5), 359-364 (2010-08-13) Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer.Hiroshi Tsubamoto et al.Anticancer research, 34(5), 2481-2487 (2014-04-30) Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial.Chee Khoon Lee et al.Gynecologic oncology, 136(1), 18-24 (2014-10-05) Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.Haiquan Lu et al.Proceedings of the National Academy of Sciences of the United States of America, 112(33), E4600-E4609 (2015-08-01) [Substance P in antitumor drug-induced adverse reactions].Takahisa Yano et al.Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 142(5), 255-255 (2013-11-12) Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.Seung Ah Choi et al.Neuro-oncology, 17(6), 810-821 (2014-11-08) Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer.Jung-Min Lee et al.Journal of translational medicine, 13, 239-239 (2015-07-23) Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy.Jakob Lauritsen et al.International journal of cancer, 135(7), 1733-1739 (2014-03-04) Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients.Kulthida Rithirangsriroj et al.Gynecologic oncology, 136(1), 82-86 (2014-12-03) Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.Eva Tonsing-Carter et al.Molecular cancer therapeutics, 14(12), 2850-2863 (2015-10-24) Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.Dong-Sheng Zhou et al.World journal of gastroenterology, 21(18), 5582-5590 (2015-05-20) The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer.Minchen Liu et al.Frontiers in oncology, 10, 1453-1453 (2020-08-28) Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?Nikola A Bowden Cancer letters, 346(2), 163-171 (2014-01-28) Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.Christopher Bryant et al.BMC cancer, 14, 570-570 (2014-08-12) VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.Erick Riquelme et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 20(14), 3849-3861 (2014-05-23) Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer.Ahmad A Tarhini et al.Anticancer research, 33(10), 4475-4481 (2013-10-15) Osteoblasts support megakaryopoiesis through production of interleukin 9Xiao M, et al. Blood, blood-b2016 (2017) [Locally advanced granulocyte colony-stimulating factor-producing non-small cell lung cancer successfully treated with concurrent chemoradiotherapy].Tetsuya Yokosuka et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(12), 2330-2332 (2014-01-08) Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.Brian H Kushner et al.Cancer, 119(3), 665-671 (2012-09-07) p53 protein aggregation promotes platinum resistance in ovarian cancer.Y Yang-Hartwich et al.Oncogene, 34(27), 3605-3616 (2014-09-30) Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer.Robert C Doebele et al.Cancer, 121(6), 883-892 (2014-11-08) Response to: 'Letter to the editor, European Journal of Cancer', commenting on 'Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma'.Scott T C Shepherd et al.European journal of cancer (Oxford, England : 1990), 50(12), 2178-2179 (2014-06-01) [Safety and efficacy of pegylated liposomal Doxorubicin and Carboplatin on platinum-sensitive recurrent epithelial ovarian cancer].Shin Nishio et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(13), 2539-2543 (2013-12-18) Therapeutic efficacy of paclitaxel and carboplatin via arterial or venous perfusion in rabbits with VX-2 tongue cancer.Ni-Ni Zhang et al.International journal of clinical and experimental medicine, 8(4), 4979-4988 (2015-07-02) Serum miR-335 Level is Associated with the Treatment Response to Trans-Arterial Chemoembolization and Prognosis in Patients with Hepatocellular Carcinoma.Liming Cui et al.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 37(1), 276-283 (2015-08-26) Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.Miho Muraji et al.Gynecologic oncology, 131(3), 531-534 (2013-10-08) Hepatoblastoma and hypoplastic kidneys: a new association.Randall Chan et al.Pediatric blood & cancer, 61(8), 1476-1478 (2014-03-14) Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma.Stéphanie Lheureux et al.International journal of cancer, 136(5), E340-E350 (2014-07-30) Osteoblasts support megakaryopoiesis through production of interleukin 9Xiao M, et al. Blood, blood-b2016 (2017) Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature.Osnat Ashur-Fabian et al.Anti-cancer drugs, 24(3), 315-323 (2013-01-26) Treatment of invasive squamous cell carcinomas in an open Clagett window.Natasha Atanaskova Mesinkovska et al.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 41(1), 170-172 (2015-01-01) Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.Yujiro Ito et al.BMC cancer, 15, 324-324 (2015-05-01) RNAi-mediated knockdown of the CLN3 gene inhibits proliferation and promotes apoptosis in drug-resistant ovarian cancer cells.Dongwei Mao et al.Molecular medicine reports, 12(5), 6635-6641 (2015-08-25) [Carcinosarcoma of the ovary treated with paclitaxel and carboplatin chemotherapy - a report of 4 cases].Isao Otsuka et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(9), 1249-1253 (2013-09-21) Synchronous auditory nerve activity in the carboplatin-chinchilla model of auditory neuropathy.C D Cowper-Smith et al.The Journal of the Acoustical Society of America, 128(1), EL56-EL62 (2010-07-24) Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin.Chel Hun Choi et al.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(5), 1181-1187 (2013-12-18) Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.Yujun Wang et al.Cancer letters, 358(2), 170-179 (2014-12-30) SALL4 is a new target in endometrial cancer.Li A, Jiao Y, Yong KJ, et al. Oncogene, 34(1), 63-72 (2015) APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.N Mohell et al.Cell death & disease, 6, e1794-e1794 (2015-06-19) Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin.O Heudi et al.Biopharmaceutics & drug disposition, 20(2), 107-116 (1999-04-17) Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.Olga Karginova et al.Molecular cancer therapeutics, 14(4), 920-930 (2015-04-01) Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.Katrina N Slaughter et al.Gynecologic oncology, 133(1), 11-15 (2014-04-01) A shotgun approach for the identification of platinum-protein complexes.Irene Moraleja et al.Analytical and bioanalytical chemistry, 407(9), 2393-2403 (2015-01-27) Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer.Kazushige Wakuda et al.American journal of clinical oncology, 38(1), 28-32 (2013-02-08) Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer.Hiroaki Takeoka et al.Japanese journal of clinical oncology, 44(5), 472-478 (2014-04-02) Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue.Brian J Gebhardt et al.American journal of clinical oncology, 37(6), 535-538 (2013-02-23) Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.Semra Utku et al.The Journal of pharmacy and pharmacology, 66(11), 1593-1605 (2014-08-12) Comparative Pharmacokinetics and Allometric Scaling of Carboplatin in Different Avian Species.Gunther Antonissen et al.PloS one, 10(7), e0134177-e0134177 (2015-07-30) Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.Mihaly Cserepes et al.European journal of cancer (Oxford, England : 1990), 50(10), 1819-1828 (2014-04-29) Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.Lu Yang et al.International journal of clinical and experimental medicine, 8(8), 13690-13698 (2015-11-10) [Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy].Hideaki Ito et al.Gan to kagaku ryoho. Cancer & chemotherapy, 38(3), 481-484 (2011-03-16) Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner.Akiko Morimoto et al.Oncotarget, 5(17), 7776-7787 (2014-10-04) Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.Sayo Horibe et al.Life sciences, 124, 31-40 (2015-01-28) Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.Szu-Jung Chen et al.Biochemical pharmacology, 95(1), 28-37 (2015-03-25) Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Alexander Laemmle et al.Molecular genetics and metabolism, 114(3), 438-444 (2015-02-03) Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.Virginie F Viprey et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(10), 1074-1083 (2014-03-05) Downfall of iniparib: a PARP inhibitor that doesn't inhibit PARP after all.Gunjan Sinha Journal of the National Cancer Institute, 106(1), djt447-djt447 (2014-01-10)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交